648 related articles for article (PubMed ID: 22301498)
61. Well-differentiated liposarcoma primary from thymic stroma: Case report and literature review.
Furlan K; Miller I; Rohra P; Mir F; Ocampo Gonzalez FA; Gattuso P
Exp Mol Pathol; 2020 Oct; 116():104517. PubMed ID: 32791064
[TBL] [Abstract][Full Text] [Related]
62. Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma.
Creytens D; van Gorp J; Savola S; Ferdinande L; Mentzel T; Libbrecht L
Virchows Arch; 2014 Jul; 465(1):97-108. PubMed ID: 24659226
[TBL] [Abstract][Full Text] [Related]
63. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas.
Deyrup AT; Chibon F; Guillou L; Lagarde P; Coindre JM; Weiss SW
Am J Surg Pathol; 2013 Sep; 37(9):1373-8. PubMed ID: 23887155
[TBL] [Abstract][Full Text] [Related]
64. CD10 (neprilysin) expression: a potential adjunct in the distinction of hibernoma from morphologic mimics.
Gjorgova-Gjeorgjievski S; Fritchie K; Folpe AL
Hum Pathol; 2021 Apr; 110():12-19. PubMed ID: 33406387
[TBL] [Abstract][Full Text] [Related]
65. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
Thway K; Jones RL; Noujaim J; Zaidi S; Miah AB; Fisher C
Adv Anat Pathol; 2016 Jan; 23(1):30-40. PubMed ID: 26645460
[TBL] [Abstract][Full Text] [Related]
66. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G
J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978
[TBL] [Abstract][Full Text] [Related]
67. Clinical Application of Chromosome Microarray Analysis in the Diagnosis of Lipomatous Tumors.
Pei J; Flieder DB; Talarchek JN; Cooper HS; Patchefsky AS; Wei S
Appl Immunohistochem Mol Morphol; 2021 Sep; 29(8):592-598. PubMed ID: 33734108
[TBL] [Abstract][Full Text] [Related]
68. Well-Differentiated Liposarcoma With Hibernoma-Like Morphology.
Hallin M; Schneider N; Thway K
Int J Surg Pathol; 2016 Oct; 24(7):620-2. PubMed ID: 27272683
[TBL] [Abstract][Full Text] [Related]
69. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
70. Expanding the differential of cutaneous epithelioid tumors: A case of dedifferentiated liposarcoma with epithelioid features involving the skin, with review of the literature.
Chambers M; Badin DJ; Sriharan AA; Linos KD
J Cutan Pathol; 2020 Jun; 47(6):554-560. PubMed ID: 31995237
[TBL] [Abstract][Full Text] [Related]
71. A novel sclerosing atypical lipomatous tumor/well-differentiated liposarcoma in a 7-year-old girl: report of a case with molecular confirmation.
Peng R; Chen H; Yang X; Zhang X; Zhang Z; He X; Zhang H
Hum Pathol; 2018 Jan; 71():41-46. PubMed ID: 28705709
[TBL] [Abstract][Full Text] [Related]
72. Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient.
Kukull BJ; Khalighi MA; Gundle KR; Hansford BG; Corless CL; Davis JL
Pediatr Dev Pathol; 2020; 23(3):240-246. PubMed ID: 31739757
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM
J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
[TBL] [Abstract][Full Text] [Related]
74. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
75. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
[TBL] [Abstract][Full Text] [Related]
76. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria.
Clay MR; Martinez AP; Weiss SW; Edgar MA
Am J Surg Pathol; 2015 Oct; 39(10):1433-9. PubMed ID: 26146760
[TBL] [Abstract][Full Text] [Related]
77. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
78. Primary intrathoracic liposarcomas: A clinicopathologic and molecular study of 43 cases in one of the largest medical centers of China.
Xie Y; Jing W; Zhao W; Peng R; Chen M; Lan T; Peng H; He X; Chen H; Zhang Z; Zhang H
Front Oncol; 2022; 12():949962. PubMed ID: 36059611
[TBL] [Abstract][Full Text] [Related]
79. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.
Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K
Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275
[TBL] [Abstract][Full Text] [Related]
80. Primary Breast Atypical Lipomatous Tumor/ Well-Differentiated Liposarcoma and Dedifferentiated Liposarcoma.
Briski LM; Jorns JM
Arch Pathol Lab Med; 2018 Feb; 142(2):268-274. PubMed ID: 29372852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
